Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Trifluoromethylepinephrine Compounds and Methods of Making and Using Thereof, 13183-13184 [05-5328]

Download as PDF Federal Register / Vol. 70, No. 52 / Friday, March 18, 2005 / Notices Dated: March 14, 2005. Jeannette Owings-Ballard, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 05–5432 Filed 3–17–05; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Notification of an Open Meeting of the Board of Visitors (BOV), National Defense University National Defense University. Notice; meeting of Board of Visitors (BOV) at NDU. AGENCY: ACTION: SUMMARY: The President, National Defense University has scheduled a meeting of the Board of Visitors. Request subject notice be published in the Federal Register. The National Wherein R1—R5 are each independently selected from the group consisting of H, alkyl, alkoxyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, acyl, thioacyl, suffonyl mercapto, alkylthio, carboxy, amino, alkylamino dialkylamino, carbamoyl, arylthio, and VerDate jul<14>2003 16:14 Mar 17, 2005 Jkt 205001 Defense University Board of Visitors is a Federal Advisory Board. The Board meets twice a year in proceedings that are open to the Public. The meeting will be held on April 18 and 19, 2005 from 11 a.m. to 5 p.m. on the 18th and continuing on the 19th from 8:30 a.m. to 1:30 p.m. Location: The Board of Visitors meeting will be held at Building 62, Marshall Hall, Room 155, National Defense University, 300 5th Avenue, Fort McNair, Washington, DC 20319– 5066. DATES: The point of contact for this notice of an ‘‘Open Meeting’’ is Ms. Tonya Barbee at (202) 6885–3539, Fax (202) 685–3935 or barbee@ndu.edu. FOR FURTHER INFORMATION CONTACT: The future agenda will include discussions on Defense transformation, faculty development facilities, information technology, curriculum development, post 9/11 initiatives as well as other operational issued and areas of interests affecting the day-to-day operations of the National Defense University and its components. The meeting is open to the public; limited space made available for observers will be allocated on a first come, first served basis. SUPPLEMENTARY INFORMATION: Dated: March 14, 2005. Jeannette Owings-Ballard, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 05–5431 Filed 3–17–05; 8:45 am] BILLING CODE 5001–06–M heteroarylthio; wherein X, Y, and Z are each independently selected from the group consisting of H or trifluoromethyl with the proviso that at least one of which is trifluoromethyl. Also disclosed are pharmaceutical compositions comprising the PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Trifluoromethylepinephrine Compounds and Methods of Making and Using Thereof Department of the Army, DoD. Notice. AGENCY: ACTION: SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent No. 6,825,382 entitled ‘‘Trifluoromethylepinephrine Compounds and Methods of Making and Using Thereof,’’ issued November 30, 2004. Foreign rights are also available (PCT/US03/05976). The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–ZA–J, 504 Scott Street, Fort Detrick, Frederick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: Disclosed herein are trifluoromethylepinephrine compounds having the following structural forumula (I): trifluoromethylepinephrine compounds and methods of making and using thereof. Novel E:\FR\FM\18MRN1.SGM 18MRN1 EN18MR05.004</GPH> economical research and development program in the area of electron devices. The AGED meeting will be limited to review of research and development programs which the Military Departments propose to initiate with industry, universities or in their laboratories. The agenda for this meeting will include programs on microwave technology microelectronics, electro-optics, and electronics materials. In accordance with Section 10(d) of Pub. L. No. 92–463, as amended, (5 U.S.C. App.2 § 10(d)), it has been determined that this Advisory Group meeting concerns matters listed in 5 U.S.C. 552b(c)(1), and that accordingly, this meeting will be closed to the public. 13183 13184 Federal Register / Vol. 70, No. 52 / Friday, March 18, 2005 / Notices trifluoromethylepinephrine intermediates are also disclosed. Brenda S. Bowen, Army Federal Register Liaison Officer. FR Doc. 05–5328 Filed 3–17–05; 8:45 am] BILLING CODE 3710–08–M (866) 208–3676 (toll free). For TTY, call (202) 502–8659. Comment Date: 5 p.m. eastern time on April 4, 2005. Magalie R. Salas, Secretary. [FR Doc. E5–1205 Filed 3–17–05; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF ENERGY DEPARTMENT OF ENERGY Federal Energy Regulatory Commission Federal Energy Regulatory Commission [Docket No. CP04–101–001] [Docket No. RP05–202–001] Columbia Natural Resources, LLC; Notice of Compliance Filing March 14, 2005. Take notice that on February 25, 2005, Columbia Natural Resources, LLC pursuant with the Commission’s ‘‘Order on Petition for Declaratory Order,’’ 110 FERC ¶ 61,062 (2005), filed a service agreement with Allegheny Power as a special rate schedule under section 154.112(a) of the Commission’s regulations. Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission’s Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant and all the parties in this proceeding. The Commission encourages electronic submission of protests and interventions in lieu of paper using the ‘‘eFiling’’ link at https://www.ferc.gov. Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426. This filing is accessible on-line at https://www.ferc.gov, using the ‘‘eLibrary’’ link and is available for review in the Commission’s Public Reference Room in Washington, DC. There is an ‘‘eSubscription’’ link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail FERCOnlineSupport@ferc.gov, or call VerDate jul<14>2003 16:14 Mar 17, 2005 Jkt 205001 Panhandle Eastern Pipe Line Company, LP; Notice of Proposed Changes in FERC Gas Tariff March 11, 2005. Take notice that on March 9, 2005, Panhandle Eastern Pipe Line Company, LP (Panhandle) tendered for filing as part of its FERC Gas Tariff, Third Revised Volume No. 1, the revised tariff sheets in Appendix B attached to the filing, to become effective April 1, 2005. Panhandle states that the purpose of this filing, made in accordance with section 24 (Fuel Reimbursement Adjustment) of the General Terms and Conditions in Panhandle’s FERC Gas Tariff, Third Revised Volume No. 1, is to replace Appendix B, Page 6, which contained an incorrect amount for the projected annual throughput for the Market Zone. Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission’s Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed in accordance with the provisions of Section 154.210 of the Commission’s regulations (18 CFR 154.210). Anyone filing an intervention or protest must serve a copy of that document on the Applicant. Anyone filing an intervention or protest on or before the intervention or protest date need not serve motions to intervene or protests on persons other than the Applicant. The Commission encourages electronic submission of protests and interventions in lieu of paper using the ‘‘eFiling’’ link at https://www.ferc.gov. Persons unable to file electronically should submit an original and 14 copies PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426. This filing is accessible on-line at https://www.ferc.gov, using the ‘‘eLibrary’’ link and is available for review in the Commission’s Public Reference Room in Washington, DC. There is an ‘‘eSubscription’’ link on the Web site that enables subscribers to receive email notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please email FERCOnlineSupport@ferc.gov, or call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. Magalie R. Salas, Secretary. [FR Doc. E5–1176 Filed 3–17–05; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. ER03–256–004, et al.] TXU Pedricktown Cogeneration Company LP, et al.; Electric Rate and Corporate Filings March 11, 2005. The following filings have been made with the Commission. The filings are listed in ascending order within each docket classification. 1. TXU Pedricktown Cogeneration Company LP [Docket No. ER03–256–004] Take notice that on March 8, 2005, TXU Pedricktown Cogeneration Company LP (TXU Pedricktown) tendered for filing a compliance filing consisting of its triennial market power update and its third revised marketbased rate schedule reflecting the incorporation of the reporting requirement adopted by the Commission in Order No. 652 issued February 10, 2005, Reporting Requirement for Changes in Status for Public Utilities with Market-Based Rate Authority, 110 FERC ¶ 61,097 (2005). Comment Date: 5 p.m. eastern time on March 29, 2005. 2. FirstEnergy Solutions Corp. [Docket No. ER04–652–003] Take notice that on March 8, 2005, FirstEnergy Solutions Corp. (Solutions) submitted revisions to Service Schedule A-Reactive Supply and Voltage Control from Generation Sources Service under its tariff for sales of ancillary services E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 70, Number 52 (Friday, March 18, 2005)]
[Notices]
[Pages 13183-13184]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5328]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Trifluoromethylepinephrine 
Compounds and Methods of Making and Using Thereof

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,825,382 
entitled ``Trifluoromethylepinephrine Compounds and Methods of Making 
and Using Thereof,'' issued November 30, 2004. Foreign rights are also 
available (PCT/US03/05976). The United States Government, as 
represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Disclosed herein are 
trifluoromethylepinephrine compounds having the following structural 
forumula (I):
[GRAPHIC] [TIFF OMITTED] TN18MR05.004

Wherein R\1\--R\5\ are each independently selected from the group 
consisting of H, alkyl, alkoxyl, aryl, heteroaryl, cycloalkyl, 
heterocycloalkyl, acyl, thioacyl, suffonyl mercapto, alkylthio, 
carboxy, amino, alkylamino dialkylamino, carbamoyl, arylthio, and 
heteroarylthio; wherein X, Y, and Z are each independently selected 
from the group consisting of H or trifluoromethyl with the proviso that 
at least one of which is trifluoromethyl. Also disclosed are 
pharmaceutical compositions comprising the trifluoromethylepinephrine 
compounds and methods of making and using thereof. Novel

[[Page 13184]]

trifluoromethylepinephrine intermediates are also disclosed.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
FR Doc. 05-5328 Filed 3-17-05; 8:45 am]
BILLING CODE 3710-08-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.